Tech Company Financing Transactions
Nutrinia Funding Round
On 8/19/2016, Nutrinia raised $30 million in Series D financing from TPG Biotech, H.I.G. Capital and WuXi PharmaTech.
Transaction Overview
Company Name
Announced On
8/19/2016
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series D
Investors
Proceeds Purpose
Nutrinia will use the proceeds to initiate two pivotal trials for registration in separate indications related to acceleration of gut maturation and adaptation: intestinal malabsorption in preterm newborns born between 26 and 32 weeks' gestational age, and infants with SBS who are under 12 months old.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
106 Allen Rd. 4th Floor
Basking Ridge, NJ 07920
USA
Basking Ridge, NJ 07920
USA
Phone
Website
Email Address
Overview
Nutrinia is a neonatology company developing pharmaceuticals to treat rare conditions of the gastrointestinal tract. Our current products in development are oral formulations of insulin shown to enhance adaptation and rehabilitation of the gut in infants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jill Quigley
Chief Marketing Officer
Nader Youssef
Founder
Naim Shehadeh
VP - Finance
Thomas Biancardi
VP - Operations
Jon Beauchamp
Browse more venture capital transactions:
Prev: 8/19/2016: Swee10 venture capital transaction
Next: 8/19/2016: Puls venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs